| __timestamp | Bausch Health Companies Inc. | Exelixis, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 6008900000 | 23068000 |
| Thursday, January 1, 2015 | 7853800000 | 33277000 |
| Friday, January 1, 2016 | 7063000000 | 184902000 |
| Sunday, January 1, 2017 | 6176000000 | 437411000 |
| Monday, January 1, 2018 | 6029000000 | 827478000 |
| Tuesday, January 1, 2019 | 6251000000 | 934678000 |
| Wednesday, January 1, 2020 | 5778000000 | 951266000 |
| Friday, January 1, 2021 | 6040000000 | 1382097000 |
| Saturday, January 1, 2022 | 5760000000 | 1553153000 |
| Sunday, January 1, 2023 | 6198000000 | 1757661000 |
| Monday, January 1, 2024 | 2168701000 |
In pursuit of knowledge
In the ever-evolving landscape of the pharmaceutical industry, Exelixis, Inc. and Bausch Health Companies Inc. have showcased intriguing financial trajectories over the past decade. From 2014 to 2023, Bausch Health consistently maintained a robust gross profit, peaking in 2015 with a 30% increase from the previous year. However, a slight decline was observed in 2022, with profits dipping by approximately 4% compared to 2021.
Conversely, Exelixis, Inc. has demonstrated a remarkable growth story. Starting from a modest base in 2014, the company experienced a staggering 7,500% increase in gross profit by 2023. This growth trajectory highlights Exelixis's strategic advancements and market positioning.
These trends underscore the dynamic nature of the pharmaceutical sector, where strategic decisions and market conditions can significantly impact financial outcomes.
Who Generates Higher Gross Profit? Johnson & Johnson or Exelixis, Inc.
Gross Profit Analysis: Comparing AbbVie Inc. and Bausch Health Companies Inc.
Amgen Inc. vs Bausch Health Companies Inc.: A Gross Profit Performance Breakdown
Vertex Pharmaceuticals Incorporated and Exelixis, Inc.: A Detailed Gross Profit Analysis
Regeneron Pharmaceuticals, Inc. vs Exelixis, Inc.: A Gross Profit Performance Breakdown
Gross Profit Analysis: Comparing Viatris Inc. and Bausch Health Companies Inc.
Gross Profit Comparison: BioMarin Pharmaceutical Inc. and Exelixis, Inc. Trends
Gross Profit Trends Compared: Walgreens Boots Alliance, Inc. vs Exelixis, Inc.
Gross Profit Analysis: Comparing Exelixis, Inc. and Lantheus Holdings, Inc.
Exelixis, Inc. vs Amneal Pharmaceuticals, Inc.: A Gross Profit Performance Breakdown
Exelixis, Inc. and Ligand Pharmaceuticals Incorporated: A Detailed Gross Profit Analysis
Who Generates Higher Gross Profit? Ascendis Pharma A/S or Bausch Health Companies Inc.